Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02792790 · ClinicalTrials.gov registry record
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 96
- Enrollment target
NCT02792790: Completed study, sponsored by The Cleveland Clinic.
NCT02792790 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02792790 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
The investigators will prospectively evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid in the soft tissue that is removed. Patients who have tissue that stains positive for amyloid will undergo cardiac testing to look for evidence of cardiac involvement.
Primary Outcome
Identify the incidence of TTR amyloid deposits in the soft tissue of patients undergoing carpal tunnel surgery for idiopathic carpal tunnel syndrome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-12-02 |
What the finished NCT02792790 record still lists
NCT02792790 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02792790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02792790 about?
NCT02792790 is a clinical study titled "Carpal Tunnel Syndrome and Amyloid Cardiomyopathy". The investigators will prospectively evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid in the soft tissue that is removed. Patients who have tissue that stains positive for amyloid will undergo cardiac testing to look for evidence of cardiac involvem...
What is the current status of trial NCT02792790?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2016-03. Estimated completion is 2021-12-02.
Who is sponsoring clinical trial NCT02792790?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia